Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kyntra Bio (KYNB) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $4.0 million.

  • Kyntra Bio's Shares Outstanding (Weighted Average) rose 57.2% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 57.2%. This contributed to the annual value of $100.0 million for FY2024, which is 281.7% up from last year.
  • Kyntra Bio's Shares Outstanding (Weighted Average) amounted to $4.0 million in Q3 2025, which was up 57.2% from $4.0 million recorded in Q2 2025.
  • Over the past 5 years, Kyntra Bio's Shares Outstanding (Weighted Average) peaked at $101.0 million during Q1 2025, and registered a low of $4.0 million during Q2 2024.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $75.2 million, with a median of $93.5 million in 2022.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 477.57% in 2023, then crashed by 9591.42% in 2024.
  • Kyntra Bio's Shares Outstanding (Weighted Average) (Quarter) stood at $92.3 million in 2021, then increased by 1.34% to $93.6 million in 2022, then rose by 3.98% to $97.3 million in 2023, then increased by 2.82% to $100.0 million in 2024, then crashed by 95.96% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $4.0 million for Q2 2025, and $101.0 million during Q1 2025.